The role of the transcription factor AP-1 in colitis-associated and β-catenin-dependent intestinal tumorigenesis in mice

Oncogene

Volumn 27, Issue 47, 2008, Pages 6102-6109

  Hasselblatt, P ^a,c   Gresh, L ^a,d   Kudo, H ^a   Guinea Viniegra, J ^a,b   Wagner, E F ^a,b  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c UNIVERSITY OF FREIBURG   (Germany)

^d DSI CSIR Nanotechnology Innovation Centre   (South Africa)

Author keywords

APC; Azoxymethane; c Fos; c Jun; Colitis associated cancer; Colorectal carcinoma

Indexed keywords

BETA CATENIN; PROTEIN C JUN; PROTEIN FOS; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR JUNB;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CARCINOGENESIS; CELL PROLIFERATION; COLITIS; COLON CANCER; COMPETITIVE INHIBITION; INTESTINE EPITHELIUM; INTESTINE TUMOR; MOLECULAR DYNAMICS; MOUSE; MUTANT; NONHUMAN; ONCOGENE; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMALL INTESTINE;

ANIMALS; AZOXYMETHANE; BETA CATENIN; COLITIS; COLONIC NEOPLASMS; GENES, APC; INTESTINAL MUCOSA; MICE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

MUS;

EID: 54049122614     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.211     Document Type: Article

References (38)

1. Andreu P, Colnot S, Godard C, Gad S, Chafey P, Niwa-Kawakita M et al. (2005). Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Development 132: 1443-1451.
2. Bantel H, Schmitz ML, Raible A, Gregor M, Schulze-Osthoff K. (2002). Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness. FASEB J 16: 1832-1834.
3. Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A et al. (2004). TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21: 491-501.
4. Behrens A, Sibilia M, David JP, Mohle-Steinlein U, Tronche F, Schutz G et al. (2002). Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J 21: 1782-1790.
5. Clarke AR. (2006). Wnt signalling in the mouse intestine. Oncogene 25: 7512-7521.
6. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. (1999). Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8: 265-277.
7. Clevers H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
8. Eferl R, Hoebertz A, Schilling AF, Rath M, Karreth F, Kenner L et al. (2004). The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J 23: 2789-2799.
9. Eferl R, Wagner EF. (2003). AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868.
10. Eferl R, Zenz R, Theussl HC, Wagner EF. (2007). Simultaneous generation of fra-2 conditional and fra-2 knock-out mice. Genesis 45: 447-451.
11. el Marjou F, Janssen KP, Chang BH, Li M, Hindie V, Chan L et al. (2004). Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39: 186-193.
12. Fleischmann A, Hvalby O, Jensen V, Strekalova T, Zacher C, Layer LE et al. (2003). Impaired long-term memory and NR2A-type NMDA receptor-dependent synaptic plasticity in mice lacking c-Fos in the CNS. J Neurosci 23: 9116-9122.
13. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al. (2004). IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
14. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M et al. (1999). Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 18: 5931-5942.
15. Hasselblatt P, Rath M, Komnenovic V, Zatloukal K, Wagner EF. (2007). Hepatocyte survival in acute hepatitis is due to c-Jun/ AP-1-dependent expression of inducible nitric oxide synthase. Proc Natl Acad Sci USA 104: 17105-17110.
16. Hulit J, Wang C, Li Z, Albanese C, Rao M, Di Vizio D et al. (2004). Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice. Mol Cell Biol 24: 7598-7611.
17. Janne PA, Mayer RJ. (2000). Chemoprevention of colorectal cancer. N Engl J Med 342: 1960-1968.
18. Kenner L, Hoebertz A, Beil T, Keon N, Karreth F, Eferl R et al. (2004). Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J Cell Biol 164: 613-623.
19. Kinzler KW, Vogelstein B. (1996). Lessons from hereditary colorectal cancer. Cell 87: 159-170.
20. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M et al. (1999). Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 96: 1603-1608.
21. Meixner A, Karreth F, Kenner L, Wagner EF. (2004). JunD regulates lymphocyte proliferation and T helper cell cytokine expression. EMBO J 23: 1325-1335.
22. Nateri AS, Spencer-Dene B, Behrens A. (2005). Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 437: 281-285.
23. Radtke F, Clevers H. (2005). Self-renewal and cancer of the gut: two sides of a coin. Science 307: 1904-1909.
24. Sabapathy K, Kallunki T, David JP, Graef I, Karin M, Wagner EF. (2001). c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J Exp Med 193: 317-328.
25. Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR et al. (2007). Myc deletion rescues Apc deficiency in the small intestine. Nature 446: 676-679.
26. Sansom OJ, Reed KR, Hayes AJ, Ireland H, Brinkmann H, Newton IP et al. (2004). Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 18: 1385-1390.
27. Sansom OJ, Reed KR, van de Wetering M, Muncan V, Winton DJ, Clevers H et al. (2005). Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine. J Biol Chem 280: 28463-28467.
28. Shaulian E, Karin M. (2002). AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E131-E136.
29. Shibata H, Toyama K, Shioya H, Ito M, Hirota M, Hasegawa S et al. (1997). Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278: 120-123.
30. Suzuki R, Kohno H, Sugie S, Tanaka T. (2004). Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate. Cancer Sci 95: 721-727.
31. Takahashi M, Wakabayashi K. (2004). Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 95: 475-480.
32. Taketo MM. (2006). Wnt signaling and gastrointestinal tumorigenesis in mouse models. Oncogene 25: 7522-7530.
33. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. (2003). A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 94: 965-973.
34. Thepot D, Weitzman JB, Barra J, Segretain D, Stinnakre MG, Babinet C et al. (2000). Targeted disruption of the murine junD gene results in multiple defects in male reproductive function. Development 127: 143-153.
35. Tong C, Yin Z, Song Z, Dockendorff A, Huang C, Mariadason J et al. (2007). c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression. Am J Pathol 171: 297-303.
36. Wagner EF, Eferl R. (2005). Fos/AP-1 proteins in bone and the immune system. Immunol Rev 208: 126-140.
37. Wang H, Birkenbach M, Hart J. (2000). Expression of Jun family members in human colorectal adenocarcinoma. Carcinogenesis 21: 1313-1317.
38. Wang HL, Wang J, Xiao SY, Haydon R, Stoiber D, He TC et al. (2002). Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Int J Cancer 101: 301-310.